Ligand validation:3DHH

BML: 4-BROMOPHENOL

BML is a Ligand Of Interest in 3DHH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3DHH_BML_E_507	74%	59%	0.138	0.968	0.61	0.95	-	-	2	0	100%	0.75
3DHH_BML_A_504	49%	72%	0.172	0.919	0.48	0.61	-	-	1	0	100%	0.75
3DHH_BML_A_503	42%	70%	0.242	0.962	0.69	0.48	-	-	7	0	100%	0.5
3DHH_BML_A_507	27%	55%	0.291	0.938	0.71	1.02	-	-	8	0	100%	0.5625
3DHH_BML_B_508	6%	29%	0.328	0.762	0.99	1.84	-	3	5	0	100%	1
3RMK_BML_D_496	95%	76%	0.084	0.987	0.47	0.47	-	-	5	0	100%	0.7
1XU3_BML_B_1293	90%	2%	0.1	0.984	3.58	3.25	6	5	0	0	100%	1
1T0S_BML_B_331	87%	2%	0.099	0.971	3.63	3.31	5	5	0	0	100%	1
4HSX_BML_B_203	46%	1%	0.2	0.937	3.72	3.74	3	6	4	0	100%	0.4
3O7N_BML_B_192	17%	60%	0.318	0.902	0.48	1.05	-	1	0	0	100%	0.28

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.